The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas
Open accessAbstract
Background.: High-grade gliomas with mutations in the isocitrate dehydrogenase (IDH) gene family confer longer overall survival relative to their IDH-wild-type counterparts. Accurate determination of the IDH genotype preoperatively may have both prognostic and diagnostic value. The current study used a machine-learning algorithm to generate a model predictive of IDH genotype in high-grade gliomas based on clinical variables and multimodal features extracted from conventional MRI. Methods.: Preoperative MRIs were obtained for 120 patients with primary grades III (n = 35) and IV (n = 85) glioma in this retrospective study. IDH genotype was confirmed for grade III (32/35, 91%) and IV (22/85, 26%) tumors by immunohistochemistry, spectrometry-based mutation genotyping (OncoMap), or multiplex exome sequencing (OncoPanel). IDH1 and IDH2 mutations were mutually exclusive, and all mutated tumors were collapsed into one IDH-mutated cohort. Cases were randomly assigned to either the training (n = 90) or validation cohort (n = 30). A total of 2970 imaging features were extracted from pre- and postcontrast T1-weighted, T2-weighted, and apparent diffusion coefficient map. Using a random forest algorithm, nonredundant features were integrated with clinical data to generate a model predictive of IDH genotype. Results.: Our model achieved accuracies of 86% (area under the curve [AUC] = 0.8830) in the training cohort and 89% (AUC = 0.9231) in the validation cohort. Features with the highest predictive value included patient age as well as parametric intensity, texture, and shape features. Conclusion.: Using a machine-learning algorithm, we achieved accurate prediction of IDH genotype in high-grade gliomas with preoperative clinical and MRI features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Textural Features for Image Classification
Haralick, R. M., Shanmugam, K., & Dinstein, I. (1973) · IEEE Transactions on Systems, Man, and Cybernetics · doi:10.1109/tsmc.1973.4309314 · Cited by 22,886
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Self-citationOstrom, Q. T., Gittleman, H., Fulop, J., Liu, M., Blanda, R., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov189 · Cited by 2,139
Insulator dysfunction and oncogene activation in IDH mutant gliomas
Flavahan, W. A., Drier, Y., Liau, B. B., Gillespie, S. M., Venteicher, A. S., Stemmer-Rachamimov, A. O., Suvà, M. L., & Bernstein, B. E. (2016) · Nature · doi:10.1038/nature16490 · Cited by 1,288
Hartmann, C., Meyer, J., Balss, J., Capper, D., Mueller, W., Christians, A., Felsberg, J., Wolter, M., Mawrin, C., Wick, W., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0561-9 · Cited by 1,163
High-throughput oncogene mutation profiling in human cancer
Thomas, R. K., Baker, A. C., DeBiasi, R. M., Winckler, W., LaFramboise, T., Lin, W. M., Wang, M., Feng, W., Zander, T., MacConaill, L. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1975 · Cited by 988
Zacharaki, E. I., Wang, S., Chawla, S., Soo Yoo, D., Wolf, R., Melhem, E. R., & Davatzikos, C. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22147 · Cited by 855
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
Choi, C., Ganji, S. K., DeBerardinis, R. J., Hatanpaa, K. J., Rakheja, D., Kovacs, Z., Yang, X.-L., Mashimo, T., Raisanen, J. M., Marin-Valencia, I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2682 · Cited by 839
Hartmann, C., Hentschel, B., Wick, W., Capper, D., Felsberg, J., Simon, M., Westphal, M., Schackert, G., Meyermann, R., Pietsch, T., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0781-z · Cited by 829
Paugh, B. S., Qu, C., Jones, C., Liu, Z., Adamowicz-Brice, M., Zhang, J., Bax, D. A., Coyle, B., Barrow, J., Hargrave, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7252 · Cited by 654
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
Houillier, C., Wang, X., Kaloshi, G., Mokhtari, K., Guillevin, R., Laffaire, J., Paris, S., Boisselier, B., Idbaih, A., Laigle-Donadey, F., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f96282 · Cited by 535
Wagle, N., Berger, M. F., Davis, M. J., Blumenstiel, B., DeFelice, M., Pochanard, P., Ducar, M., Van Hummelen, P., MacConaill, L. E., Hahn, W. C., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0184 · Cited by 533
Improving tumour heterogeneity MRI assessment with histograms
Just, N. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.512 · Cited by 497
Beiko, J., Suki, D., Hess, K. R., Fox, B. D., Cheung, V., Cabral, M., Shonka, N., Gilbert, M. R., Sawaya, R., Prabhu, S. S., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not159 · Cited by 456
Andronesi, O. C., Kim, G. S., Gerstner, E., Batchelor, T., Tzika, A. A., Fantin, V. R., Vander Heiden, M. G., & Sorensen, A. G. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002693 · Cited by 438
IDH mutations in glioma and acute myeloid leukemia
Dang, L., Jin, S., & Su, S. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.002 · Cited by 370
Pieper, S., Halle, M., & Kikinis, R. (2004) · International Symposium on Biomedical Imaging · Cited by 357
Pope, W. B., Prins, R. M., Albert Thomas, M., Nagarajan, R., Yen, K. E., Bittinger, M. A., Salamon, N., Chou, A. P., Yong, W. H., Soto, H., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0737-8 · Cited by 318
Macyszyn, L., Akbari, H., Pisapia, J. M., Da, X., Attiah, M., Pigrish, V., Bi, Y., Pal, S., Davuluri, R. V., Roccograndi, L., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov127 · Cited by 301
Carrillo, J. A., Lai, A., Nghiemphu, P. L., Kim, H. J., Phillips, H. S., Kharbanda, S., Moftakhar, P., Lalaezari, S., Yong, W., Ellingson, B. M., et al. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2950 · Cited by 299
Cancer-associated IDH mutations: biomarker and therapeutic opportunities
Yen, K. E., Bittinger, M. A., Su, S. M., & Fantin, V. R. (2010) · Oncogene · doi:10.1038/onc.2010.444 · Cited by 296
Pieper, S., Lorensen, B., Schroeder, W., & Kikinis, R. (2006) · 3rd IEEE International Symposium on Biomedical Imaging: Macro to Nano, 2006. · doi:10.1109/isbi.2006.1625012 · Cited by 293
Metellus, P., Coulibaly, B., Colin, C., de Paula, A. M., Vasiljevic, A., Taieb, D., Barlier, A., Boisselier, B., Mokhtari, K., Wang, X. W., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0777-8 · Cited by 289
Probabilistic Radiographic Atlas of Glioblastoma Phenotypes
Ellingson, B. M., Lai, A., Harris, R. J., Selfridge, J. M., Yong, W. H., Das, K., Pope, W. B., Nghiemphu, P. L., Vinters, H. V., Liau, L. M., et al. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3253 · Cited by 222
Drabycz, S., Roldán, G., de Robles, P., Adler, D., McIntyre, J. B., Magliocco, A. M., Cairncross, J. G., & Mitchell, J. R. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.09.049 · Cited by 205
Fuller, G. N., & Scheithauer, B. W. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00084.x · Cited by 191
for the Children’s Oncology Group, Pollack, I. F., Hamilton, R. L., Sobol, R. W., Nikiforova, M. N., Lyons-Weiler, M. A., LaFramboise, W. A., Burger, P. C., Brat, D. J., Rosenblum, M. K., et al. (2011) · Child's Nervous System · doi:10.1007/s00381-010-1264-1 · Cited by 185
QI, S., YU, L., LI, H., OU, Y., QIU, X., DING, Y., HAN, H., & ZHANG, X. (2014) · Oncology Letters · doi:10.3892/ol.2014.2013 · Cited by 169
Saraswathy, S., Crawford, F. W., Lamborn, K. R., Pirzkall, A., Chang, S., Cha, S., & Nelson, S. J. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9685-3 · Cited by 158
Apparent diffusion coefficient histograms may predict low‐grade glioma subtype
Tozer, D. J., Jäger, H. R., Danchaivijitr, N., Benton, C. E., Tofts, P. S., Rees, J. H., & Waldman, A. D. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1091 · Cited by 154
Ellingson, B. M. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0506-0 · Cited by 132
Brown, R. A., Ƶlatescu, M. C., Sijben, A. E. J., Roldán, G. B., Easaw, J., Forsyth, P. A., Parney, I. F., Sevick, R. J., Yan, E., Demetrick, D. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1964 · Cited by 123
MR Imaging–Based Analysis of Glioblastoma Multiforme: Estimation ofIDH1Mutation Status
Yamashita, K., Hiwatashi, A., Togao, O., Kikuchi, K., Hatae, R., Yoshimoto, K., Mizoguchi, M., Suzuki, S. O., Yoshiura, T., & Honda, H. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4491 · Cited by 123
A Generic Support Vector Machine Model for Preoperative Glioma Survival Associations
Emblem, K. E., Pinho, M. C., Zöllner, F. G., Due‐Tønnessen, P., Hald, J. K., Schad, L. R., Meling, T. R., Rapalino, O., & Bjørnerud, A. (2014) · Radiology · doi:10.1148/radiol.14140770 · Cited by 112
Lee, S., Choi, S. H., Ryoo, I., Yoon, T. J., Kim, T. M., Lee, S., Park, C., Kim, J., Sohn, C., Park, S., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1614-z · Cited by 106
Somatic mutations associated with MRI-derived volumetric features in glioblastoma
Gutman, D. A., Dunn, W. D., Großmann, P., Cooper, L., Holder, C. A., Ligon, K. L., Alexander, B. M., & Aerts, H. J. W. L. (2015) · Neuroradiology · doi:10.1007/s00234-015-1576-7 · Cited by 105
Self-citationChang, J. S.-M., Yeh, R., Wiencke, J. K., Wiemels, J. L., Smirnov, I. V., Pico, A. R., Tihan, T., Patoka, J., Miike, R., Sison, J. D., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2830 · Cited by 90
Sonoda, Y., Shibahara, I., Kawaguchi, T., Saito, R., Kanamori, M., Watanabe, M., Suzuki, H., Kumabe, T., & Tominaga, T. (2014) · Brain Tumor Pathology · doi:10.1007/s10014-014-0211-3 · Cited by 79
Ellingson, B. M., Malkin, M. G., Rand, S. D., LaViolette, P. S., Connelly, J., Mueller, W. M., & Schmainda, K. M. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0293-7 · Cited by 78
Survival Analysis of Patients with High-Grade Gliomas Based on Data Mining of Imaging Variables
Zacharaki, E. I., Morita, N., Bhatt, P., O’Rourke, D. M., Melhem, E. R., & Davatzikos, C. A. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2939 · Cited by 77
Ranjith, G., Parvathy, R., Vazhayil, V. V., Kesavadas, C., & Nair, S. (2015) · The Neuroradiology Journal · doi:10.1177/1971400915576637 · Cited by 75
Cryan, J. B., Haidar, S., Ramkissoon, L. A., Bi, W. L., Knoff, D. S., Schultz, N. D., Abedalthagafi, M., Brown, L. E., Wen, P. Y., Reardon, D. A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2342 · Cited by 59
Self-citationPredicting MGMT Methylation Status of Glioblastomas from MRI Texture
Levner, I., Drabycz, S., Roldán, G. B., de Robles, P. A., Cairncross, J. G., & Mitchell, R. (2009) · Lecture notes in computer science · doi:10.1007/978-3-642-04271-3_64 · Cited by 56
Ramkissoon, S. H., Bi, W. L., Schumacher, S. E., Ramkissoon, L. A., Haidar, S., Knoff, D. S., Dubuc, A. M., Brown, L. E., Burns, M., Cryan, J. B., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov015 · Cited by 51
Self-citationHuang, R. Y., Rahman, R. M., Hamdan, A., Kane, C., Chen, C., Norden, A. D., Reardon, D. A., Mukundun, S., & Wen, P. Y. (2013) · Cancer · doi:10.1002/cncr.28210 · Cited by 31
Self-citationHigh Throughput Tools to Access Images from Clinical Archives for Research
Murphy, S. N., Herrick, C. D., Wang, Y., Wang, T. D., Sack, D., Andriole, K. P., Wei, J. L., Reynolds, N., Plesniak, W. J., Rosen, B. R., et al. (2014) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-014-9733-9 · Cited by 29
Liu, C., Zhang, H., Pan, Y., Huang, F., & Xia, S. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/24/8393 · Cited by 15
Cited by
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846
“…and survival, 123 IDH mutation status in high-grade and low-grade gliomas, 95,96 the presence of chromosome 1p and 19q loss in low-grade gliomas, 95,124 MGMT methylation status, 93 EGFR amplification status, 125 and the presence of EGFR receptor variant III 126 as well as EGFR extracellular…”
BackgroundSelf-citationBrain tumor detection and classification using machine learning: a comprehensive survey
Amin, J., Sharif, M., Haldorai, A., Yasmin, M., & Nayak, R. S. (2022) · Complex & Intelligent Systems · doi:10.1007/s40747-021-00563-y · Cited by 503
Chang, K., Bai, H. X., Zhou, H., Su, C., Bi, W. L., Agbodza, E., Kavouridis, V. K., Senders, J. T., Boaro, A., Beers, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2236 · Cited by 391
Self-citationMRI features predict survival and molecular markers in diffuse lower-grade gliomas
Zhou, H., Vallières, M., Bai, H. X., Su, C., Tang, H., Oldridge, D., Zhang, Z., Xiao, B., Liao, W., Tao, Y., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now256 · Cited by 354
Machine Learning–Based Radiomics for Molecular Subtyping of Gliomas
Lu, C.-F., Hsu, F.-T., Hsieh, K. L.-C., Kao, Y.-C. J., Cheng, S.-J., Hsu, J. B.-K., Tsai, P.-H., Chen, R.-J., Huang, C.-C., Yen, Y., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3445 · Cited by 306
Metadata
- Authors
- Zhang, B., Chang, K., Ramkissoon, S., Tanguturi, S., Bi, W. L., Reardon, D. A., Ligon, K. L., Alexander, B. M., Wen, P. Y., & Huang, R. Y.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06-26
- Volume
- 19
- Issue
- 1
- Pages
- 109-117
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2460918282
- Cited by
- 263
- References
- 50
- FWCI
- 23.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.